ArticleAnnals of translational medicine2016

At the crossroads from bench to bedside: luteolin is a promising pharmacological agent against myocardial ischemia reperfusion injury.

Defeng Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.